Furthermore, both drugs, through the inhibition of TEC and ERBB4, might reduce nitric oxide production, promoting atrial endothelial dysfunction, enhanced cardiac hypertrophy and fibrosis, and reduced capillary formation35. This evidence concerns the gene ERBB4 and cardiac hypertrophy.